$HURC

Hurco Stock Gains Following Q3 Earnings Showing Narrower Losses

HURC reports a narrower third-quarter fiscal 2025 loss and stronger revenues, fueled by solid demand in the Americas and Asia Pacific.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Sep 10, 2025, 4:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 11, 2025, 12:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hurco Stock Gains Following Q3 Earnings Showing Narrower Losses — source image
Decision brief

The 30-second read

$HURCNeutralLow
01

Why it matters

The earnings improvement suggests a possible positive shift in investor sentiment, but the company's overall financial health remains fragile.

02

Market read

The news has limited relevance for broader market movements but may influence short-term trading decisions for related stocks.

03

What to watch

Potential supply chain issues or macroeconomic headwinds could dampen future performance, which are not addressed in the current news.

Timing: Medium-term (next 1-3 months)

Background

Hurco reported a narrower loss and increased revenues in Q3 2025, driven by demand in key regions.

Company-level read

Ticker impact

$HURCNeutralMedium confidence
Context

The news reports a narrower loss and increased revenues for Hurco in Q3 2025, indicating improved financial performance.

Expected impact

Moderate upward movement in the short term, potential for increased investor confidence.

Evidence & confidence

The improved earnings suggest positive momentum; however, the company's still narrow losses and limited relevance score imply cautious optimism rather than strong bullish signals.

Market effects

The machinery and manufacturing sector may experience slight positive sentiment due to improved earnings reports from companies like Hurco.

Demand in the Americas and Asia Pacific could bolster regional manufacturing indices.

Limited; Hurco's performance is a specific indicator within its sector and regions, with minimal impact on global markets.

Counterpoint

The company's narrow losses may indicate underlying operational challenges, and the positive earnings could be temporary or driven by non-recurring factors.

Key entities

  • Hurco Companies, Inc.

    A manufacturer of CNC machine tools and related equipment.

Related articles

$HURCMed

HURCO COMPANIES INC (HURC): Results of Operations and Financial Condition

HURCO COMPANIES INC (HURC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ​ FOR IMMEDIATE RELEASE FRIDAY, SEPTEMBER 4, 2026 ​ HURCO REPORTS PROFIT IN THIRD QUARTER RESULTS FOR FISCAL YEAR 2026 ​ INDIANAPOLIS, INDIANA – September 4, 2026 -- Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 3

$HURCMed

Hurco Companies, Inc.: Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

Hurco Companies (HURC) reported a net income of $2.3M ($0.35/Share) for Q3 2026, reversing a $3.7M loss from Q3 2025. Sales rose 3% to $47.3M, with orders up 25%. For 9M 2026, net loss narrowed to $3.5M ($0.55/Share) from $12.1M ($1.87/Share) in 2025. Sales grew 4% to $137.8M. CEO Greg Volovic attributed profitability to cost control, higher sales volumes, and tariff refunds. The company plans to introduce new technology at IMTS in Chicago.

$BKRMed

Baker Hughes Awarded Offshore Production Enhancement and Stimulation Services Contract by bp

Baker Hughes (BKR) secured a contract from bp (BP) to provide offshore stimulation services in the UK North Sea, supporting new well development and enhanced recovery. The deal involves a vessel-based solution for efficient well completions and production enhancement, aiming to improve operational reliability and reservoir recovery. Baker Hughes will leverage its StimFORCE modular stimulation package and local supply chain network.

$TEVAMed

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

S&P Global Ratings upgraded Teva Pharmaceutical's long-term issuer credit rating to BBB- from BB+, reflecting strong financial performance and debt reduction. This is the third upgrade in recent months, with Teva now holding investment-grade ratings from all major agencies. The company's CFO attributed the upgrades to successful execution of its growth strategy and improved financial profile.

$MOMOMed

StoneX cuts Hello Group stock price target on weaker outlook

StoneX reduced its price target for Hello Group (MOMO) to $8.00 from $10.00, citing weaker domestic spending and moderating overseas growth. The company's Q2 2026 revenue declined 5% YoY, though overseas revenue grew 52% YoY. StoneX lowered its fiscal 2026 revenue forecast to a 6% YoY decline. Hello Group's stock trades at $5.39, near its 52-week low, with a P/E ratio of 8.34 and a 5.1% dividend yield.

$NBISMedAI 8/10

Billionaire Stephen Mandel’s Top 2 AI Stock Picks

Billionaire Stephen Mandel's Lone Pine Capital opened new positions in Nebius Group (NBIS) and Seagate Technology (STX) in Q2. NBIS is the largest holding, with $1.18B invested, while STX saw $965.1M invested. NBIS reported a 454% revenue increase YoY to $582.3M, driven by high demand for AI cloud services. However, the company faces risks related to high capital expenditures and potential delays in data center construction.